Rolling back a malaria epidemic in South Africa

PLoS Medicine

Volumn 2, Issue 11, 2005, Pages 1076-1077

  Duffy, Patrick E ^a,b   Mutabingwa, Theonest K ^c,d  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; FANSIDAR; ANTIMALARIAL AGENT;

ANTIBIOTIC RESISTANCE; DRUG EFFICACY; DRUG FORMULATION; ENDEMIC DISEASE; EPIDEMIC; GAMETOCYTE; HUMAN; MALARIA FALCIPARUM; PARASITE TRANSMISSION; PARASITE VECTOR; PARASITEMIA; PRIMARY HEALTH CARE; RESERVOIR; SHORT SURVEY; VECTOR CONTROL; ANIMAL; ANOPHELES; DISEASE CARRIER; DRUG COMBINATION; MOSQUITO; NOTE; PARASITOLOGY; SOUTH AFRICA;

ANIMALS; ANOPHELES; ANTIMALARIALS; DISEASE OUTBREAKS; DRUG COMBINATIONS; HUMANS; INSECT VECTORS; MALARIA, FALCIPARUM; MOSQUITO CONTROL; SOUTH AFRICA;

EID: 28444454954     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020368     Document Type: Short Survey

References (13)

1. Craig MH, Kleinschmidt I, Le Sueur D, Sharp BL (2004) Exploring 30 years of malaria case data in KwaZulu-Natal, South Africa: Part II. The impact of non-climatic factors. Trop Med Int Health 9: 1258-1266.
2. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, et al. (2005) Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2: e330. DOI: 10.1371/journal.pmed.0020330
3. Nabarro D (1999) Roll Back Malaria. Parassitologia 41: 501-504.
4. [Anonymous] (2005) Reversing the failures of Roll Back Malaria. Lancet 365: 1439.
5. White NJ (2004) Antimalarial drug resistance. J Clin Invest 113: 1084-1092.
6. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley C, et al. (2005) Reduction of malaria transmission to anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med 2: e92. DOI: 10.1371/journal.pmed.0020092
7. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, et al. (2000) Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study. Lancet 356: 297-302.
8. Tanariya P, Tippawangkoso P, Karbwang J, Na-Bangchang K, Wernsdorfer WH (2000) In vitro sensitivity of Plasmodium falciparum and clinical response to lumefantrine (benflumetol) and artemether. Br J Clin Pharmacol 49: 437-444.
9. Ittarat W, Pickard AL, Rattanasinganchan P, Wilairatana P, Looareesuwan S, et al. (2003) Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. Am J Trop Med Hyg 68: 147-152.
10. Snow RW, Trape JF, Marsh K (2001) The past, present and future of childhood malaria mortality in Africa. Trends Parasitol 17: 593-597.
11. Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, et al. (2005) Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: Randomized clinical trials from four sites in Uganda. PLoS Med 2: e190. DOI: 10.1371/journal.pmed.0020190
12. Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, et al. (2001) Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 358: 1218-1223.
13. Sisowath C, Stromberg J, Martensson A, Msellum M, Obondo C, et al. (2005) In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis 191: 1014-1017.